Risk factors for auditory neuropathy spectrum disorder in NICU infants compared to normal-hearing NICU controls

Laryngoscope

Volumn 121, Issue 4, 2011, Pages 852-855

  Coenraad, Saskia ^a   Goedegebure, André ^a   Van Goudoever, Johannes B ^a   Hoeve, L J ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

auditory neuropathy spectrum disorder; NICU, infant; Pediatric ears otology; risk factor

Indexed keywords

BILIRUBIN; DEXAMETHASONE; FUROSEMIDE; GENTAMICIN; TOBRAMYCIN; VANCOMYCIN;

APGAR SCORE; ARTICLE; AUDITORY NEUROPATHY SPECTRUM DISORDER; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; BODY DYSMORPHIC DISORDER; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HEARING; HUMAN; HYPERBILIRUBINEMIA; INFANT; MALE; MENINGITIS; NEWBORN INTENSIVE CARE; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RISK FACTOR; SEPSIS; VESTIBULOCOCHLEAR NERVE DISEASE;

ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING LOSS, CENTRAL; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; MALE; MENINGITIS, BACTERIAL; NEONATAL SCREENING; NETHERLANDS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS; VANCOMYCIN;

EID: 79953118603     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21430     Document Type: Article

References (20)

1. Rance G, Barker E, Mok M, Dowell R, Rincon A, Garratt R., Speech perception in noise for children with auditory neuropathy/dys-synchrony type hearing loss. Ear Hear 2007; 28: 351-360. (Pubitemid 46718015)
2. Starr A, Picton TW, Sininger Y, Hood LJ, Berlin CI., Auditory neuropathy. Brain 1996; 119 (Pt 3): 741-753. (Pubitemid 26237173)
3. Doyle KJ, Sininger Y, Starr A., Auditory neuropathy in childhood. Laryngoscope 1998; 108: 1374-1377. (Pubitemid 28411369)
4. Vlastarakos PV, Nikolopoulos TP, Tavoulari E, Papacharalambous G, Korres S., Auditory neuropathy: endocochlear lesion or temporal processing impairment? Implications for diagnosis and management. Int J Pediatr Otorhinolaryngol 2008; 72: 1135-1150.
5. Rapin I, Gravel J., "Auditory neuropathy": physiologic and pathologic evidence calls for more diagnostic specificity. Int J Pediatr Otorhinolaryngol 2003; 67: 707-728. (Pubitemid 36677535)
6. Berg AL, Spitzer JB, Towers HM, Bartosiewicz C, Diamond BE., Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission. Pediatrics 2005; 116: 933-938. (Pubitemid 44542821)
7. Dowley AC, Whitehouse WP, Mason SM, Cope Y, Grant J, Gibbin KP., Auditory neuropathy: unexpectedly common in a screened newborn population. Dev Med Child Neurol 2009; 51: 642-646.
8. Xoinis K, Weirather Y, Mavoori H, Shaha SH, Iwamoto LM., Extremely low birth weight infants are at high risk for auditory neuropathy. J Perinatol 2007; 27: 718-723. (Pubitemid 350020354)
9. Kirkim G, Serbetcioglu B, Erdag TK, Ceryan K., The frequency of auditory neuropathy detected by universal newborn hearing screening program. Int J Pediatr Otorhinolaryngol 2008; 72: 1461-1469.
10. Coenraad S, van Immerzeel T, Hoeve LJ, Goedegebure A., Fitting model of ABR age dependency in a clinical population of normal hearing children. Eur Arch Otorhinolaryngol 2010; 267: 1531-1537.
11. Berlin CI, Hood LJ, Morlet T, et al. Multi-site diagnosis and management of 260 patients with auditory neuropathy/dys-synchrony (auditory neuropathy spectrum disorder). Int J Audiol 2010; 49: 30-43.
12. Sawada S, Mori N, Mount RJ, Harrison RV., Differential vulnerability of inner and outer hair cell systems to chronic mild hypoxia and glutamate ototoxicity: insights into the cause of auditory neuropathy. J Otolaryngol 2001; 30: 106-114. (Pubitemid 34272952)
13. Meyer C, Witte J, Hildmann A, et al. Neonatal screening for hearing disorders in infants at risk: incidence, risk factors, and follow-up. Pediatrics 1999; 104 (4 Pt 1): 900-904. (Pubitemid 29463558)
14. Bassler D, Stoll BJ, Schmidt B, et al. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics 2009; 123: 313-318.
15. de Hoog M, van Zanten BA, Hop WC, Overbosch E, Weisglas-Kuperus N, van den Anker JN., Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss. J Pediatr 2003; 142: 41-46. (Pubitemid 36106386)
16. de Vries LS, Lary S, Dubowitz LM., Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 1985; 76: 351-354. (Pubitemid 15242495)
17. Gallaher KJ, Maisels MJ., Relationship between bilirubin and hearing loss. Pediatrics 1986; 77: 929-930.
18. Yilmaz Y, Degirmenci S, Akdas F, et al. Prognostic value of auditory brainstem response for neurologic outcome in patients with neonatal indirect hyperbilirubinemia. J Child Neurol 2001; 16: 772-775. (Pubitemid 33150170)
19. Shapiro SM, Nakamura H., Bilirubin and the auditory system. J Perinatol 2001; 21 (Suppl 1): S52-55; discussion S59-62. (Pubitemid 34055874)
20. Rance G, Beer DE, Cone-Wesson B, et al. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear 1999; 20: 238-252. (Pubitemid 29279321)